This week a federal grand jury returned an indictment charging Dr. Stephen Dubin with what prosecutors call a $95 million Medicare fraud scheme. Officials say he billed Medicare for expensive amniotic wound allografts that were not medically needed, pocketed the difference, and even used kickbacks to keep the racket going. For anyone who still believes medicine is always a calling, this case is a rude reminder that where big money flows, bad actors follow.
What the indictment alleges about Stephen Dubin and Medicare fraud
The Department of Justice says Dr. Stephen Dubin, owner of Dubin Medical Consultants (aka Wound MD), caused Medicare to be billed for more than $95 million in allograft claims. Prosecutors say Medicare actually paid more than $54 million on those claims. The indictment alleges illegal kickbacks, bribes, sham rebate deals and fake bills that hid how little Dubin actually paid for the products. It also alleges the allografts were used on elderly patients — even some in hospice — when there was no medical reason to do so.
Why this case matters: elder exploitation, Medicare waste, and trust betrayed
Healthcare fraud is theft. The DOJ warns these schemes steal resources from seniors who need care. Assistant Attorney General Colin M. McDonald called the scheme “driven by greed, not medicine,” and the FBI’s Special Agent in Charge Christopher S. Delzotto called it a “betrayal of trust.” Those are harsh words but the facts described in the indictment back them up: prosecutors say records were falsified and products were chosen for profit, not patients. Taxpayers and vulnerable seniors paid the bill.
Broader enforcement and the policy backdrop
This is not an isolated complaint. Federal prosecutors have been cracking down on amniotic allograft and skin‑substitute billing across multiple districts. CMS changed payment rules in 2026 to blunt payment incentives that ran wild under the old system, and the White House’s anti‑fraud push — led in part by Vice President J.D. Vance — has highlighted millions in stopped fraud and suspended providers. Prosecutors and investigators from the FBI, HHS‑OIG, and other agencies are clearly treating these schemes as a high priority.
What comes next — and the plain takeaway
An indictment is an allegation, and Dr. Dubin is presumed innocent until proven guilty. Next steps are arrest or summons, arraignment, and the usual court process. But the larger lesson is straightforward: when reimbursement rules make room for huge markups, someone with little scruple will exploit that gap and seniors will get hurt. The Justice Department deserves credit for moving on this indictment. Now it should follow the money all the way up the chain — distributors, marketers, and anyone else who treated Medicare like a private ATM. If you steal from Grandpa and Grandma, expect a long legal wakeup call.

